LDS/Medical Tests/Hepatitis B Surface Antibody, Qualitative or Quantitative

Hepatitis B Surface Antibody, Qualitative or Quantitative

Hepatitis B infection is caused by the Hepatitis B Virus and is responsible for mortality everywhere in the world. Hepatitis B virus is spread by contact with contaminated blood and body fluids. Chronic infection with Hepatitis B virus results in damage to the liver, ultimately resulting in liver disease, cirrhosis, and/or liver cancer. The body’s immune system is responsible for the liver tissue damage because it destroys the liver cells containing the virus. Consumption of alcohol during infection with Hepatitis B virus is discouraged as it can increase the damage to the liver. Hepatitis B virus is prevented by cautious and safe exposure to blood or body fluids, vaccination, and refraining from behavior known to be associated with the possibility of infection. Serology testing to detect hepatitis B surface antigen (HBsAg), is the standard for diagnosing the disease. HBsAg is produced by the virus itself and is used to detect a current infection of Hepatitis B. Antibody to Hepatitis B surface antigen (HBsAb) is used to evaluate immunity status (acquired from the hepatitis B vaccine and to determine if there has been a past infection with HBV). An increase in anti-HBsAb levels, together with a loss of detectable circulating HBsAg indicates convalescence in hepatitis B infections. Furthermore, HBsAb can be used to determine if vaccination is needed or, following a vaccination regimen, to determine if protective immunity has been achieved.

  • Diagnosis of HBV disease associated with HBV infection
  • Evaluation of immune status to HBV
  • Differential diagnosis of hepatitis of unknown etiology

Positive in:

  • Hepatitis B immunity due to HBV infection or hepatitis B vaccination

Absent in:

  • Hepatitis B carrier state
  • Lack of exposure/infection

Positive result implies immunity or previous infection
Negative result implies no prior exposure and no immunity

Negative (Non-reactive)
 

 

Enzyme immunoassay, Chemiluminescent immunoassay.

Serum (SST) or Plasma EDTA (Lavender) or Plasma Heparin. 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Total anti-HBc (Hepatitis B Core Antibody), IgG Anti-HBVc, HBV DNA by PCR, Liver Enzymes (Liver Function Tests).
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Am J Med. 2005;118 (Suppl 10A):28S. [PMID: 16271538]
  • Clin Liver Dis. 2004;8:267. [PMID: 15481340]
  • Gastroenterol Clin Biol. 2008 Jan;32(1 Pt 2):S56-63. [PMID: 18662611]
  • N Engl J Med. 2004 Mar 11;350(11):1118-29. [PMID: 15014185]
  • Stevens, CD. Clinical Immunology & Serology A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company (2010).
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).